Business Services Industry

PATIENTS PREFER ORAL ERECTILE DYSFUNCTION TREATMENT: STUDY.

AsiaPulse News, November, 2003

(Full text of a statement, contact details below)

COLOGNE, Nov. 17 /PRNewswire-AsiaNet/ - Results of a new clinical study indicate that most men with erectile dysfunction (ED) prefer the new PDE5-inhibitor drugs to sildenafil (Viagra) and of these, nearly one-half of men prefer vardenafil (Levitra)(1), the product most recently approved in Europe and the United States. The direct comparison study is being presented for the first time today at the 6th Congress of the European Society for Sexual Medicine (ESSM) in Istanbul.

In terms of overall preference, most men rated vardenafil as the preferred option (47 per cent) compared with tadalafil (19 per cent) or sildenafil (34 per cent) at the recommended starting dose. Vardenafil was also the preferred option at...

Premium Content Partnership

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement
Click Here

Most Recent Business Articles

Most Recent Business Publications

Most Popular Business Articles

Most Popular Business Publications